Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Best Practices for Sentinel Events: What Every Healthcare Organization Needs to Know

In any healthcare environment, patient safety is always top of mind. Each staff member is responsible for their own actions. Administrators are too, especially when those actions include reacting to a safety concern raised by an employee. To ensure that healthcare organizations have a high-reliability culture, the Joint Commission Center for Transforming Healthcare published a…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In any healthcare environment, patient safety is always top of mind. Each staff member is responsible for their own actions. Administrators are too, especially when those actions include reacting to a safety concern raised by an employee. To ensure that healthcare organizations have a high-reliability culture, the Joint Commission Center for Transforming Healthcare published a report, “Sentinel Event Alert 60: Developing a Reporting Culture: Learning from Close Calls and Hazardous Conditions.” 1 The Joint Commission issued this report to encourage a reporting culture where swift action is taken to remedy unsafe conditions.

What Is a Sentinel Event?

The Joint Commission’s mission is “to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value.2 The Joint Commission defines a sentinel event as an unanticipated event in a healthcare setting resulting in death or serious injury, physical or psychological, not related to natural causes or the patient’s illness. The Joint Commission identifies sentinel events in its accreditation policies to assist with root cause analysis and the development of new preventive measures. Accredited organizations are required to define sentinel events for their own care system and implement monitoring procedures and a process for root cause analysis.

Standards Must Be in Place to Respond to a Sentinel Event

Should a sentinel event occur, any accredited healthcare organization must have a process to respond. Causal factors need to be analyzed, focusing on the system holistically. An “action plan” should be put in place for potential improvements to decrease the chance of the event happening again. The Joint Commission encourages organizations to report any sentinel event, but it’s not required. The organization will have to create root cause analysis and an action plan within 45 days of the event. You can also consult with The Joint Commission on initiating the root cause analysis and action plan. If the event was due to a medical device defect, then an organization must report the incident to the Food and Drug Administration within 10 days.

There are benefits to reporting the event that can be of help to other organizations. A reported event is added to the database which other facilities have access to, providing vital information that could help to prevent a similar event from occurring at their organizations.

Sentinel Event Standards

Within the Performance Improvement and Leadership chapters of the accreditation manual, there are standards for the expectations regarding the internal identification and management of sentinel events.

With the organization’s definition of the sentinel event, it must include the specific events that would be reviewed under the Sentinel Event Policy. Following a sentinel event, the organization must begin its investigation by determining root cause analysis, then develop its plan and identify ways to reduce future risk. After the standards are implemented, they are closely monitored to ascertain their viability.

Reporting Is a Key Element of Sentinel Event Management

In order to manage sentinel events, your culture must be one that has adopted reporting. Only with reporting will you be able to truly understand the causes of a particular event and prevent similar events from happening again. The four Es of a Reporting Culture include:3

  1. Establish trust: there can be no culture of reporting without trust; leaders must show their continued commitment to safety and governance should support this as well.
  2. Encourage reporting: this means that reporting is accessible by all staff, easy to use, and delivers data analysis in a timely fashion. Encouragement also means that staff receives feedback so that they know the action is being taken when reports are made. The organization should also define the types of events that should be reported.
  3. Eliminate fear of punishment: ensure that your staff knows that there is no retaliation or punishment for reporting safety concerns. All staff, regardless of position, should be held to the same standards.
  4. Examine errors: refer to the data compiled and use it to identify the highest risk situations and take action. Data is also used to celebrate staff when they are successful. Data helps strengthen the safety program and the culture of reporting.

The Joint Commission also offers resources and support so you can continue to enhance a culture of reporting within your organization.4

https://www.alimed.com/_resources/common/userfiles/file/infographics/AliMed_ReportingCulture-Infographic.pdf

References

  1. https://www.jointcommission.org/
  2. https://www.jointcommission.org
  3. https://www.jointcommission.org/
  4. https://www.jointcommission.org/

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512